In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://dx.doi.org/10.1016/j.biopha.2018.10.057 http://hdl.handle.net/11449/189671 |
Resumo: | In order to improve the previously observed antichagasic activity of Cu(II) complexes containing 2-chlorobenzhydrazide (2-CH), we report herein the synthesis and anti-Trypanosoma cruzi activity of novel copper complexes containing 2-methoxybenzhydrazide (2-MH), 4-methoxybenzhydrazide (4-MH) and three α-diimine ligands, namely, 1,10-phenanthroline (phen), 2,2-bipyridine (bipy) and 4-4′-dimethoxy-2-2′-bipyridine (dmb). Two of these complexes showed higher in vitro anti-Trypanosoma cruzi activity when compared to benznidazole, the main drug used in Chagas disease treatment. One of them, the copper complex with 4-MH and dmb, [Cu(4-MH)(dmb)(ClO 4 ) 2 ], exhibited a higher selectivity index than that recommended for preclinical studies. Considering this observation, complex [Cu(4-MH)(dmb)(ClO 4 ) 2 ] was selected for preliminary in vivo assays, which verified that this compound was able to reduce parasitemia by 64% at the peak of infection. Further investigations were performed on all compounds. The Cu(II) complexes bind to ct-DNA with K b values in the range of 10 3 –10 4 M –1 , with [Cu(4-MH)(dmb)(ClO 4 ) 2 ] showing the highest K b value (1.45 × 10 4 M –1 ). Molecular docking simulations predicted that [Cu(4-MH)(dmb)(ClO 4 ) 2 ] binds in the minor groove of the double helix of ct-DNA and forms one hydrogen bond. |
id |
UNSP_eb10036991b54a30c4206999850ea109 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/189671 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complexChagas diseaseCu(II) complexesDNA bindingHydrazidesMolecular dockingT. cruziIn order to improve the previously observed antichagasic activity of Cu(II) complexes containing 2-chlorobenzhydrazide (2-CH), we report herein the synthesis and anti-Trypanosoma cruzi activity of novel copper complexes containing 2-methoxybenzhydrazide (2-MH), 4-methoxybenzhydrazide (4-MH) and three α-diimine ligands, namely, 1,10-phenanthroline (phen), 2,2-bipyridine (bipy) and 4-4′-dimethoxy-2-2′-bipyridine (dmb). Two of these complexes showed higher in vitro anti-Trypanosoma cruzi activity when compared to benznidazole, the main drug used in Chagas disease treatment. One of them, the copper complex with 4-MH and dmb, [Cu(4-MH)(dmb)(ClO 4 ) 2 ], exhibited a higher selectivity index than that recommended for preclinical studies. Considering this observation, complex [Cu(4-MH)(dmb)(ClO 4 ) 2 ] was selected for preliminary in vivo assays, which verified that this compound was able to reduce parasitemia by 64% at the peak of infection. Further investigations were performed on all compounds. The Cu(II) complexes bind to ct-DNA with K b values in the range of 10 3 –10 4 M –1 , with [Cu(4-MH)(dmb)(ClO 4 ) 2 ] showing the highest K b value (1.45 × 10 4 M –1 ). Molecular docking simulations predicted that [Cu(4-MH)(dmb)(ClO 4 ) 2 ] binds in the minor groove of the double helix of ct-DNA and forms one hydrogen bond.Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG)Instituto de Química Universidade Federal de Uberlândia, Campus Santa MônicaDepartamento de Análises Clínicas Toxicológicas e Bromatológicas Faculdade de Ciências Farmacêuticas de Ribeirão Preto Universidade de São PauloNúcleo de Pesquisa em Produtos Naturais e Sintéticos (NPPNS) Faculdade de Ciências Farmacêuticas de Ribeirão Preto Universidade de São PauloDepartamento de Química Universidade Federal de Juiz de Fora Juiz de Fora-MGInstituto de Física de São Carlos Universidade de São PauloUNESP - Universidade Estadual Paulista Instituto de QuímicaDepartamento de Física Instituto de Ciências Exatas Naturais e Educação Universidade Federal do Triângulo MineiroUNESP - Universidade Estadual Paulista Instituto de QuímicaFAPEMIG: APQ-00330-14Universidade Federal de Uberlândia (UFU)Universidade de São Paulo (USP)Juiz de Fora-MGUniversidade Estadual Paulista (Unesp)Universidade Federal do Triângulo MineiroPaixão, Drielly A.Lopes, Carla D.Carneiro, Zumira A.Sousa, Luana M.de Oliveira, Leticia P.Lopes, Norberto P.Pivatto, MarcosChaves, Joana Darc S.de Almeida, Mauro V.Ellena, JavierMoreira, Mariete B. [UNESP]Netto, Adelino V.G. [UNESP]de Oliveira, Ronaldo J.Guilardi, Silvanade Albuquerque, SérgioGuerra, Wendell2019-10-06T16:48:23Z2019-10-06T16:48:23Z2019-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article157-166http://dx.doi.org/10.1016/j.biopha.2018.10.057Biomedicine and Pharmacotherapy, v. 109, p. 157-166.1950-60070753-3322http://hdl.handle.net/11449/18967110.1016/j.biopha.2018.10.0572-s2.0-85055895361Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengBiomedicine and Pharmacotherapyinfo:eu-repo/semantics/openAccess2021-10-22T21:15:51Zoai:repositorio.unesp.br:11449/189671Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462021-10-22T21:15:51Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex |
title |
In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex |
spellingShingle |
In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex Paixão, Drielly A. Chagas disease Cu(II) complexes DNA binding Hydrazides Molecular docking T. cruzi |
title_short |
In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex |
title_full |
In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex |
title_fullStr |
In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex |
title_full_unstemmed |
In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex |
title_sort |
In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex |
author |
Paixão, Drielly A. |
author_facet |
Paixão, Drielly A. Lopes, Carla D. Carneiro, Zumira A. Sousa, Luana M. de Oliveira, Leticia P. Lopes, Norberto P. Pivatto, Marcos Chaves, Joana Darc S. de Almeida, Mauro V. Ellena, Javier Moreira, Mariete B. [UNESP] Netto, Adelino V.G. [UNESP] de Oliveira, Ronaldo J. Guilardi, Silvana de Albuquerque, Sérgio Guerra, Wendell |
author_role |
author |
author2 |
Lopes, Carla D. Carneiro, Zumira A. Sousa, Luana M. de Oliveira, Leticia P. Lopes, Norberto P. Pivatto, Marcos Chaves, Joana Darc S. de Almeida, Mauro V. Ellena, Javier Moreira, Mariete B. [UNESP] Netto, Adelino V.G. [UNESP] de Oliveira, Ronaldo J. Guilardi, Silvana de Albuquerque, Sérgio Guerra, Wendell |
author2_role |
author author author author author author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Federal de Uberlândia (UFU) Universidade de São Paulo (USP) Juiz de Fora-MG Universidade Estadual Paulista (Unesp) Universidade Federal do Triângulo Mineiro |
dc.contributor.author.fl_str_mv |
Paixão, Drielly A. Lopes, Carla D. Carneiro, Zumira A. Sousa, Luana M. de Oliveira, Leticia P. Lopes, Norberto P. Pivatto, Marcos Chaves, Joana Darc S. de Almeida, Mauro V. Ellena, Javier Moreira, Mariete B. [UNESP] Netto, Adelino V.G. [UNESP] de Oliveira, Ronaldo J. Guilardi, Silvana de Albuquerque, Sérgio Guerra, Wendell |
dc.subject.por.fl_str_mv |
Chagas disease Cu(II) complexes DNA binding Hydrazides Molecular docking T. cruzi |
topic |
Chagas disease Cu(II) complexes DNA binding Hydrazides Molecular docking T. cruzi |
description |
In order to improve the previously observed antichagasic activity of Cu(II) complexes containing 2-chlorobenzhydrazide (2-CH), we report herein the synthesis and anti-Trypanosoma cruzi activity of novel copper complexes containing 2-methoxybenzhydrazide (2-MH), 4-methoxybenzhydrazide (4-MH) and three α-diimine ligands, namely, 1,10-phenanthroline (phen), 2,2-bipyridine (bipy) and 4-4′-dimethoxy-2-2′-bipyridine (dmb). Two of these complexes showed higher in vitro anti-Trypanosoma cruzi activity when compared to benznidazole, the main drug used in Chagas disease treatment. One of them, the copper complex with 4-MH and dmb, [Cu(4-MH)(dmb)(ClO 4 ) 2 ], exhibited a higher selectivity index than that recommended for preclinical studies. Considering this observation, complex [Cu(4-MH)(dmb)(ClO 4 ) 2 ] was selected for preliminary in vivo assays, which verified that this compound was able to reduce parasitemia by 64% at the peak of infection. Further investigations were performed on all compounds. The Cu(II) complexes bind to ct-DNA with K b values in the range of 10 3 –10 4 M –1 , with [Cu(4-MH)(dmb)(ClO 4 ) 2 ] showing the highest K b value (1.45 × 10 4 M –1 ). Molecular docking simulations predicted that [Cu(4-MH)(dmb)(ClO 4 ) 2 ] binds in the minor groove of the double helix of ct-DNA and forms one hydrogen bond. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-10-06T16:48:23Z 2019-10-06T16:48:23Z 2019-01-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1016/j.biopha.2018.10.057 Biomedicine and Pharmacotherapy, v. 109, p. 157-166. 1950-6007 0753-3322 http://hdl.handle.net/11449/189671 10.1016/j.biopha.2018.10.057 2-s2.0-85055895361 |
url |
http://dx.doi.org/10.1016/j.biopha.2018.10.057 http://hdl.handle.net/11449/189671 |
identifier_str_mv |
Biomedicine and Pharmacotherapy, v. 109, p. 157-166. 1950-6007 0753-3322 10.1016/j.biopha.2018.10.057 2-s2.0-85055895361 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Biomedicine and Pharmacotherapy |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
157-166 |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
|
_version_ |
1792961842857902080 |